March 17, 2008Heart
Anthracycline associated cardiotoxicity in survivors of childhood cancer
Why the study?
Does anthracycline chemotherapy increase the risk of severe cardiovascular toxicity in long-term survivors of childhood cancer?
Population
Long-term survivors of childhood cancer
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
May warrant closer cardiac surveillance in survivors; extends evidence on anthracycline cardiotoxicity to inform prevention trials.
Structured PICO
Does anthracycline chemotherapy increase the risk of severe cardiovascular toxicity in long-term survivors of childhood cancer?
P
Population
Long-term survivors of childhood cancer
I
Intervention
Anthracycline chemotherapy
O
Outcome
Cardiovascular toxicity (including congestive heart failure and cardiac death)safety
Long-term survivors of childhood cancer face a substantially elevated risk of severe cardiovascular conditions, particularly congestive heart failure and cardiac death, highlighting the need to manage the late cardiotoxic effects of anthracyclines.
Cite This Study
Lipshultz et al. (2008) studied this question.